Disease activity impacts disability progression in primary progressive multiple sclerosis

被引:16
|
作者
Marrodan, M. [1 ]
Bensi, C. [1 ]
Pappolla, A. [2 ]
Rojas, J. I. [2 ,3 ]
Gaitan, M. I. [1 ]
Ysrraelit, M. C. [1 ]
Negrotto, L. [1 ]
Fiol, M. P. [1 ]
Patrucco, L. [2 ,3 ]
Cristiano, E. [3 ]
Farez, M. F. [1 ,4 ]
Correale, J. [1 ]
机构
[1] Fleni, Dept Neurol, Montaneses 2325, RA-1428 Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Dept Neurol, Buenos Aires, DF, Argentina
[3] Ctr Esclerosis Multiple Buenos Aires, Buenos Aires, DF, Argentina
[4] Fleni, Ctr Biostat Epidemiol & Publ Hlth CEBES, Buenos Aires, DF, Argentina
关键词
Primary progressive multiple sclerosis; PPMS; Multiple Sclerosis; Disability worsening; Disability progression; NATURAL-HISTORY; PROGNOSTIC-FACTORS; MRI; MS; PREDICTORS;
D O I
10.1016/j.msard.2019.101892
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although solid information on the natural history of primary progressive multiple sclerosis (PPMS) is available, evidence regarding impact of disease activity on PPMS progression remains controversial. Objective: To describe the clinical characteristics, presence or absence of MRI activity, and natural history of a PPMS cohort from two referral centers in Argentina and assess whether clinical and/or radiological disease activity correlated with disability worsening. Methods: Retrospective study conducted at two MS clinics in Buenos Aires, Argentina, through comparative analysis of patients with and without evidence of disease activity. Results: Clinical and/or radiologic activity was presented in 56 (31%) of 178 patients. When stratified by age at onset, we found that for every 10 years of increase in age at onset, risk of reaching EDSS scores of 4 and 6 increased by 26% and 31%, respectively (EDSS 4: HR 1.26, CI 95%: 1.06-1.50; EDSS 6: HR 1.31, CI 95%: 1.06-1.62). Patients who presented clinical exacerbations reached EDSS scores of 6, 7 and 8 faster than those without associated exacerbations (p = 0.009, p = 0.016 and p = 0.001, respectively). Likewise, patients who presented gadolinium-enhancing lesions during the course of disease reached EDSS scores of 7 earlier (p = 0.002). Conclusion: Older age at onset and presence of clinical and/or radiological disease activity correlated with accelerated disability progression in this cohort of PPMS patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis
    Vukusic, S
    Confavreux, C
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (02) : 135 - 137
  • [32] A data-driven model of disability progression in progressive multiple sclerosis
    Garbarino, Sara
    Tur, Carmen
    Lorenzi, Marco
    Pardini, Matteo
    Piana, Michele
    Uccelli, Antonio
    Arnold, Douglas L.
    Cree, Bruce A. C.
    Sormani, Maria Pia
    Bovis, Francesca
    BRAIN COMMUNICATIONS, 2025, 7 (01)
  • [33] THE DISABILITY PROGRESSION OF MULTIPLE SCLEROSIS PROGRESSIVE COURSE: A MARKOV MODEL APPROACH
    Fornari, C.
    Cortesi, P. A.
    Capra, R.
    Cozzolino, P.
    Patti, F.
    Mantovani, L. G.
    VALUE IN HEALTH, 2020, 23 : S624 - S624
  • [34] Both relapsing-remitting and primary progressive multiple sclerosis are a two-stage disease, suggesting two consecutive mechanisms underlying the progression of disability in multiple sclerosis
    Coustans, M
    Leray, E
    Le Page, E
    Chaperon, J
    Edan, G
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S111 - S111
  • [35] ARE NEUROPHYSIOLOGICAL PARAMETERS AN OBJECTIVE MEASURE OF DISEASE STATUS AND PROGRESSION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS?
    Witherick, J.
    Kane, N.
    Butler, S.
    Walsh, P.
    Blake, K.
    Faulkner, H.
    Burrows, J.
    Inglis, K.
    Cottrell, D.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (03):
  • [36] Machine learning-based prediction of disease progression in primary progressive multiple sclerosis
    Gurevich, Michael
    Zilkha-Falb, Rina
    Sherman, Jia
    Usdin, Maxime
    Raposo, Catarina
    Craveiro, Licinio
    Sonis, Polina
    Magalashvili, David
    Menascu, Shay
    Dolev, Mark
    Achiron, Anat
    BRAIN COMMUNICATIONS, 2025, 7 (01)
  • [37] Clinical and Instrumental Findings and Disability Progression in Primary Progressive and Progressive Relapsing Multiple Sclerosis: A Comparison Study of a Sicilian Group of Patients
    Salemi, Giuseppe
    Ragonese, Paolo
    Realmuto, Sabrina
    Cammilleri, Marcella
    Lo Re, Marianna
    Mazzola, Maria Antonietta
    Lo Re, Vincenzina
    Savettieri, Giovanni
    NEUROLOGY, 2013, 80
  • [38] A novel retinal phenotype in multiple sclerosis is predictive of inflammatory disease activity and disability progression
    Saidha, S.
    Sotirchos, E.
    Ibrahim, M.
    Gelfand, J.
    Sepah, Y.
    Ratchford, J.
    Oh, J.
    Seigo, M.
    Newsome, S.
    Balcer, L.
    Frohman, E.
    Crainiceanu, C.
    Green, A.
    Nguyen, Q.
    Calabresi, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 10 - 11
  • [39] Disability Progression and Improvement Among Patients With Primary and Secondary Progressive Multiple Sclerosis in Placebo Arms of Clinical Trials
    Xun, P.
    Sadetsky, N.
    Kresa-Reahl, K.
    Bogdanovich, S.
    Barlev, A.
    Watson, C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 64 - 64
  • [40] Early corpus callosum damage predicts progression of disability over 3 years in primary progressive multiple sclerosis
    Bodini, Benedetta
    Khaleeli, Zhaleh
    Cercignani, Mara
    Miller, David H.
    Thompson, Alan J.
    Ciccarelli, Olga
    MULTIPLE SCLEROSIS, 2008, 14 : S97 - S97